Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tetradecyltrimethylammonium bromide (MitMAB) is a Dynamin GTPase activity inhibitor and a cationic surfactant with asymmetrical structure.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 g | In stock | $ 41.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 55.00 |
Description | Tetradecyltrimethylammonium bromide (MitMAB) is a Dynamin GTPase activity inhibitor and a cationic surfactant with asymmetrical structure. |
Synonyms | MitMAB, Cetrimide, tetradecyl trimethyl ammonium bromide |
Molecular Weight | 336.39 |
Formula | C17H38BrN |
CAS No. | 1119-97-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 50 mg/ml(148.64 mM)
H2O: 50 mg/ml(148.64 mM)
DMSO: 15 mg/ml(44.59 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tetradecyltrimethylammonium bromide 1119-97-7 Cytoskeletal Signaling Dynamin inhibit MitMAB Tetradecyltrimethylammonium Bromide Tetradecyltrimethylammonium tetradecyl trimethyl ammonium Bromide Inhibitor Cetrimide tetradecyl trimethyl ammonium bromide inhibitor